Globe Life Inc. $GL Shares Acquired by FJ Capital Management LLC

FJ Capital Management LLC boosted its stake in Globe Life Inc. (NYSE:GL) by 35.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 35,065 shares of the company’s stock after purchasing an additional 9,237 shares during the period. FJ Capital Management LLC’s holdings in Globe Life were worth $4,904,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock worth $1,237,000 after acquiring an additional 607 shares during the period. NewEdge Advisors LLC raised its position in Globe Life by 368.1% during the first quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock worth $897,000 after acquiring an additional 5,352 shares during the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Globe Life by 11.5% during the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock valued at $74,161,000 after acquiring an additional 58,163 shares during the last quarter. Empowered Funds LLC purchased a new stake in Globe Life in the 1st quarter worth approximately $428,000. Finally, Focus Partners Wealth boosted its stake in Globe Life by 8.3% in the 1st quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock worth $1,127,000 after buying an additional 656 shares during the last quarter. 81.61% of the stock is owned by institutional investors and hedge funds.

Globe Life Stock Up 1.0%

Shares of GL stock opened at $166.75 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. Globe Life Inc. has a 1 year low of $116.73 and a 1 year high of $168.27. The firm’s fifty day moving average price is $152.88 and its two-hundred day moving average price is $144.52. The firm has a market capitalization of $12.95 billion, a P/E ratio of 11.53 and a beta of 0.49.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, April 22nd. The company reported $3.43 EPS for the quarter, missing the consensus estimate of $3.46 by ($0.03). Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the firm posted $3.07 EPS. The business’s quarterly revenue was up 5.3% on a year-over-year basis. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, equities analysts predict that Globe Life Inc. will post 15.64 EPS for the current fiscal year.

Globe Life Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is presently 9.13%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on GL. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a research report on Thursday, March 26th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Truist Financial raised their price target on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. Morgan Stanley raised their price target on shares of Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, May 21st. Finally, Weiss Ratings raised Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday, May 13th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $174.11.

Insiders Place Their Bets

In other Globe Life news, CFO Thomas Peter Kalmbach sold 15,637 shares of the business’s stock in a transaction on Monday, May 11th. The shares were sold at an average price of $153.65, for a total value of $2,402,625.05. Following the completion of the sale, the chief financial officer directly owned 45,335 shares of the company’s stock, valued at $6,965,722.75. The trade was a 25.65% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO James Matthew Darden sold 4,663 shares of the business’s stock in a transaction dated Tuesday, April 28th. The shares were sold at an average price of $153.88, for a total value of $717,542.44. Following the transaction, the chief executive officer owned 58,451 shares in the company, valued at approximately $8,994,439.88. This represents a 7.39% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 105,929 shares of company stock worth $16,382,450 in the last ninety days. Company insiders own 2.11% of the company’s stock.

Globe Life Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.